Galderma Group AG 2023 AR2
The report highlights Galderma's financial and operational achievements in 2023, surpassing 4 billion USD in net sales for the first time. It outlines the company's Integrated Dermatology Strategy across its three core platforms: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. In terms of sustainability, the company made significant progress on its ESG roadmap, with three out of four factories operating on 100% renewable electricity and achieving zero waste to landfills across all manufacturing sites. Additionally, Galderma reduced its water intensity by more than 10% since 2019 and maintained a workforce comprising over 55% women.
Company: Galderma Group AG
Sector: Health Care
Country: Switzerland
Year: 2023
Type: AR2
Pages: 68
Galderma Group AG
Annual Review
The report highlights Galderma's financial and operational achievements in 2023, surpassing 4 billion USD in net sales for the first time. It outlines the company's Integrated Dermatology Strategy across its three core platforms: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. In terms of sustainability, the company made significant progress on its ESG roadmap, with three out of four factories operating on 100% renewable electricity and achieving zero waste to landfills across all manufacturing sites. Additionally, Galderma reduced its water intensity by more than 10% since 2019 and maintained a workforce comprising over 55% women.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees